−0.93USD
−106.001MUSD
108.145M
About CymaBay Therapeutics Inc.
Sector
Industry
CEO
Sujal Shah
Website
Headquarters
Newark
Employees (FY)
60
Founded
1988
ISIN
US23257D1037
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
CBAY - Large Symmetrical Triangle Symmetrical Triangle leading to a bullish breakout plotted using a bars pattern
Symmetrical Triangles are often considered a bullish pattern
CBAY LongAnalysis of the CBAY instrument and the possibility of its future movement relative to price ranges.
Cbay LongLooking for price to reject key level and and start to reject trendline and start making new higher higher and contiue to the upside.
CymaBay Therapeutics $CBAY - investment idea 💡 ❌ - The volume is low on daily but increasing on 4h
✅ - We got double bottom on daily
✅ - We got Bullish engulfing action few days back on the lower channel at $5.64
✅ - MACD
✅ - STOCH
✅ - DeMarker
❌ - MA50 (13% under 50MA)
✅ - MA200 (6% above 200MA)
❌ - Pivots: (7% under the pivot point)
✅ - Ra
Positive Topline Results from ENHANCE for SeladelparCymaBay Announces Positive Topline Results from ENHANCE for Seladelpar in Patients with Primary Biliary Cholangitis
-The study demonstrated seladelpar to be efficacious, safe and well-tolerated
78.2% of patients on seladelpar 10 mg versus 12.5% on placebo achieved the primary composite outcome af
CBAY enters Uptrend as Momentum indicator ascends above 0 levelThis indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. I backtested 91 similar cases where CBAY's Momentum Indicator exceeded 0, and 78 of them led t
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
